News

Indian American biomedical researcher has reported novel biomarkers for colorectal, bladder, prostate, stomach and pancreatic ...
Fujifilm’s Life Sciences Group is renaming two of its companies, in a rebranding intended to position parent company Fujifilm as a strategic partner.
If it does, AI-enabled drug discovery could prove a game-changer for pharmaceutical R&D, especially for small-molecule drug discovery, potentially allowing it to ‘catch up’ with other ...
Small-molecule drug discovery can be viewed as a challenging multidimensional problem in which various characteristics of compounds — including efficacy, pharmacokinetics and safety — need to ...
From finding promising drug candidates to creating disease-fighting models and running better clinical trials, AI is transforming the drug discovery process. This young technology is bound to ...
AI-driven drug discovery starts with identifying and validating drug targets, akin to uncovering hidden treasures within a complex biological landscape, but it doesn't end there.
The company focuses on generative and predictive AI for small molecule drug discovery using their deep learning platform, dubbed Genesis Exploration of Molecular Space (GEMS), Genesis has ...
Today, a look at Israel from three different angles: drug discovery, AI-enabled cybersecurity threats, and investor reactions to the political crisis. — Anna From spatial biology to proteomics ...
The approach to drug discovery is becoming increasingly interdisciplinary, and CAS BioFinder is designed to help build bridges and make connections faster than ever before.
AI tools neglect high-quality data inclusion during the subsequent stages of drug discovery and outcomes are uncertain based on regulatory expectations that concern late-stage AI applications. 1 ...
On a global scale, around 90% of all drugs sold are small molecules, according to a Medicine in Drug Discovery paper (2021, DOI: 10.1016/j.medidd.2020.100075).
Drug discovery startups bagged a record $5.5 billion globally in 2021, per Dealroom data. Startups are innovating ways to speed up the expensive and time-consuming process of drug discovery.